FEG
ARKG icon

Financial Enhancement Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Financial Enhancement Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,912
Closed -$4.47M – 270
2020
Q4 		$4.47M Sell
47,912
-32,119
-40% -$2.56M 0.95% 31
2020
Q3 		$5.1M Buy
+80,031
New +$4.69M 1.18% 26

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Financial Enhancement Group's ARKG Position: Q1 2021 in Review

Financial Enhancement Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 47,912 shares — an estimated $4.47M sold.

Financial Enhancement Group first reported a position in ARKG in Q3 2020 and held it in 2 quarters. The position peaked at $5.1M in Q3 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • Financial Enhancement Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • Financial Enhancement Group sold 47,912 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $4.47M.
  • Financial Enhancement Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 2 quarters.
  • Financial Enhancement Group's ARK Genomic Revolution ETF position peaked at $5.1M in Q3 2020.
  • 505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Financial Enhancement Group's 13F filing for Q1 2021, filed 10 May 2021.